86 related articles for article (PubMed ID: 10931370)
1. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
Gutmann DH; Donahoe J; Brown T; James CD; Perry A
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
Rodriguez FJ; Giannini C; Asmann YW; Sharma MK; Perry A; Tibbetts KM; Jenkins RB; Scheithauer BW; Anant S; Jenkins S; Eberhart CG; Sarkaria JN; Gutmann DH
J Neuropathol Exp Neurol; 2008 Dec; 67(12):1194-204. PubMed ID: 19018242
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.
Jeyapalan JN; Doctor GT; Jones TA; Alberman SN; Tep A; Haria CM; Schwalbe EC; Morley IC; Hill AA; LeCain M; Ottaviani D; Clifford SC; Qaddoumi I; Tatevossian RG; Ellison DW; Sheer D
Acta Neuropathol Commun; 2016 May; 4(1):54. PubMed ID: 27229157
[TBL] [Abstract][Full Text] [Related]
4. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.
Cacev T; Radosević S; Spaventi R; Pavelić K; Kapitanović S
Gut; 2005 Aug; 54(8):1129-35. PubMed ID: 15840687
[TBL] [Abstract][Full Text] [Related]
5. The molecular biology of WHO grade I astrocytomas.
Marko NF; Weil RJ
Neuro Oncol; 2012 Dec; 14(12):1424-31. PubMed ID: 23090984
[TBL] [Abstract][Full Text] [Related]
6. Obstructive Hydrocephalus Due to Aggressive Posterior Fossa Tumor Exhibiting Histological Characteristics of Pilocytic Astrocytoma in Two Adult Neurofibromatosis Type 1 (NF1) Cases.
Nawa S; Ohka F; Motomura K; Takeuchi K; Nagata Y; Yamaguchi J; Saito R
Cureus; 2024 Apr; 16(4):e58697. PubMed ID: 38779293
[TBL] [Abstract][Full Text] [Related]
7. Pediatric low-grade glioma models: advances and ongoing challenges.
Yvone GM; Breunig JJ
Front Oncol; 2023; 13():1346949. PubMed ID: 38318325
[TBL] [Abstract][Full Text] [Related]
8. Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation.
Milde T; Fangusaro J; Fisher MJ; Hawkins C; Rodriguez FJ; Tabori U; Witt O; Zhu Y; Gutmann DH
Neuro Oncol; 2023 Nov; 25(11):1920-1931. PubMed ID: 37738646
[TBL] [Abstract][Full Text] [Related]
9. Identification of an
Büki G; Bekő A; Bödör C; Urbán P; Németh K; Hadzsiev K; Fekete G; Kehrer-Sawatzki H; Bene J
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686382
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects.
Tang Y; Gutmann DH
Cancer Manag Res; 2023; 15():667-681. PubMed ID: 37465080
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Pediatric Low-Grade Gliomas.
Sait SF; Giantini-Larsen AM; Tringale KR; Souweidane MM; Karajannis MA
Curr Neurol Neurosci Rep; 2023 Apr; 23(4):185-199. PubMed ID: 36881254
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastic tumors and neurofibromatosis type 1: A retrospective multicenter study in Italy and systematic review of the literature.
Puglisi F; Soma R; Podda M; Vetrella S; Rabusin M; Tropia S; Meli M; Russo G; Sorrentino S; Erminio G; Pulvirenti A; Ruggieri M; Di Cataldo A
Front Pediatr; 2022; 10():950911. PubMed ID: 36405824
[TBL] [Abstract][Full Text] [Related]
13. Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery.
Fahmy SA; Dawoud A; Zeinelabdeen YA; Kiriacos CJ; Daniel KA; Eltahtawy O; Abdelhalim MM; Braoudaki M; Youness RA
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358663
[TBL] [Abstract][Full Text] [Related]
14. RAS and beyond: the many faces of the neurofibromatosis type 1 protein.
Anastasaki C; Orozco P; Gutmann DH
Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35188187
[TBL] [Abstract][Full Text] [Related]
15. Genetic syndromes predisposing to pediatric brain tumors.
Farouk Sait S; Walsh MF; Karajannis MA
Neurooncol Pract; 2021 Aug; 8(4):375-390. PubMed ID: 34277017
[TBL] [Abstract][Full Text] [Related]
16. Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.
Sun D; Xie XP; Zhang X; Wang Z; Sait SF; Iyer SV; Chen YJ; Brown R; Laks DR; Chipman ME; Shern JF; Parada LF
Cell Stem Cell; 2021 Aug; 28(8):1397-1410.e4. PubMed ID: 34010628
[TBL] [Abstract][Full Text] [Related]
17. Optic Nerve Gliomas.
Wladis EJ; Adamo MA; Weintraub L
J Neurol Surg B Skull Base; 2021 Feb; 82(1):91-95. PubMed ID: 33777621
[No Abstract] [Full Text] [Related]
18. Brain tumors in Neurofibromatosis type 1.
Costa AA; Gutmann DH
Neurooncol Adv; 2019; 1(1):vdz040. PubMed ID: 32642668
[TBL] [Abstract][Full Text] [Related]
19. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.
Guo X; Pan Y; Gutmann DH
Neuro Oncol; 2019 Oct; 21(10):1250-1262. PubMed ID: 31111915
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Glioma at the Optic Pathway and Thalamus.
Park ES; Park JB; Ra YS
J Korean Neurosurg Soc; 2018 May; 61(3):352-362. PubMed ID: 29742884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
